220 likes | 415 Views
Table 4.1.1: Stock and Flow of Liver Transplantation, 1993-2006. * 1 patient who was alive until 05/12/1997 is recorded died with missing date of death ** 1 patient who had transplanted in 2003 is recorded as death with missing date of death. Alive at 31st Dec. New patients. 50. 45. 40. 35.
E N D
Table 4.1.1: Stock and Flow of Liver Transplantation, 1993-2006 * 1 patient who was alive until 05/12/1997 is recorded died with missing date of death ** 1 patient who had transplanted in 2003 is recorded as death with missing date of death
Alive at 31st Dec New patients 50 45 40 35 30 Number of patients (n) 25 20 15 10 5 0 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 1993 Year Figure 4.1.1: Stock and Flow of Liver Transplantation, 1993-2006
Table 4.1.2: Distribution of Patients by Place of Transplant, 1993-2006
Table 4.1.3: Distribution of Patients by Centres for Liver Transplantation, 1993-2006 * Data was not reported
Table 4.1.4: Distribution of Transplant Recipients by Follow-up Centres, 2006 *Follow-up data was not reported
Male Female 10 8 Number of patients (n) 6 4 2 0 1995 1997 1998 1999 1994 1996 2000 2001 2002 2003 2004 2005 2006 1993 Year Figure 4.2.1: Distribution of Patients by Gender, 1993-2006
Table 4.2.2: Distribution of Patients by Ethnic Group, 1993-2006
Malay Chinese Indian Others 12 10 8 Number of patients (n) 6 4 2 0 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2005 2004 2006 Year Figure 4.2.2: Distribution of Patients by Ethnic Group, 1993-2006
Table 4.2.3: Distribution of Patients by Age, 1993-2006 * Age=date of transplant – date of birth
Table 4.2.4: Primary Diagnosis, 1993-2006 (N=88) *6 patients have more than one primary disease
Table 4.2.5: Indication for Transplantation, 1993-2006 (N=88) *21 patients had 1 indication for transplantation, 63 had more than 1 indication for transplantation
Table 4.3.1: Distribution of Patients by Type of Donors, 1993-2006 (N=88) * 1 patient is Living related - Other
Table 4.3.2: Immunosuppressive Drug Treatment at Transplantation, 1993-2006 (N=88) * 21 patients had 1 type of drug, 37 patients had 2 types, 17 patients had 3 types
Table 4.4.1: Patient Survival by Year of Transplant, 1993-2006 (N=88) SE=standard error
1.00 0.75 Cumulative survival 0.50 0.25 0.00 0 2 4 6 8 10 12 Duration in months Year 1993-1998 Year 1999-2006 Figure 4.4.1: Patient Survival by Year of Transplant, 1993-2006
Table 4.4.2: Patient Survival by Gender, 1993-2006 (N=88) SE=standard error
1.00 0.75 Cumulative survival 0.50 0.25 0.00 0 2 4 6 8 10 12 Duration in months Male Female Figure 4.4.2: Patient Survival by Gender, 1993-2006
Table 4.4.3: Patient Survival by Age Group , 1993-2006 (N=88) SE=standard error
1.00 0.75 0.50 Cumulative survival 0.25 0.00 0 2 4 6 8 10 12 Duration in months 0-9 years >=10 years Figure 4.4.3: Patient Survival by Age Group , 1993-2006
Table 4.4.4: Distribution of Patient by Cause of Death, 1993-2006 (N=88) Note: 2 patients with no date of death